维普期刊资源整合服务平台（V6.5）

41篇 您的检索式：作者名="METRO G"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	EGFR,HER2,and phospho-Akt are not predictive factors for response to first-line chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)显示文摘	Toschi L Metro G Magrini E	2006	J Clin Oncol2006，24，18：	1
2	Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotype显示文摘	Metro G Chiari R Duranti S	2012	Lung Cancer2012，78，1：	1
3	Treatment of recurrent malig- nant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation显示文摘	Fabi A Metro G Russillo M	2009	BMC Cancer2009，31，9：	1
4	Carboplatin plus pemetrexed for plat- inum-pretreated ,advanced non-small cell lung cancer: a retrospective study with pharmacogenetic evaluation显示文摘	Metro G Chiari R Mare M	2011	Cancer Chemother Pharmacol2011，68，6：	1
5	Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC) 显示文摘	Metro G Finocchiaro G Toschi L	2006	Rev Recent Clin Trials2006，1，1：	1
6	Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer:towards optimization of association and schedule 显示文摘	Metro G Fabi A Russillo M	2008	Anticancer Res2008，28，2：	1
7	Chaperone-mediated inhibition of tubulin self-assembly显示文摘	Metro G Saba A Gupta T D	2007	Proteins2007，67，1：	1
8	Treatment of recurrentmalignant gliomas with fotemustine monotherapy: impact ofdose and correlation with MGMT promoter methylation显示文摘	Fabi A Metro G Russillo M	2009	BMCCancer2009，9，：	1
9	Development of gemciabine in non-small cell lung cancer:the Italian contribution显示文摘	Metro G Cappuzzo F Finocchiaro G	2006	Annals of Oncology2006，17，5：	1
10	Emerging drugs for small - cell lung cancer 显示文摘	Metro G Cappuzzo F	2009	Expert Opin Emerging Drugs2009，14，4：	1
11	Clinical significance of PTEN and p-Akt co- expression in HER2-positive metastatic breast cancer patients treated with trastuzumab- based therapies 显示文摘	Fabi A Metro G Di Benedetto A	2010	Oncology2010，78，2：	1
12	Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center显示文摘	Fabi A Felici A Metro G	2011	J Exp Clin Cancer Res2011，30，：	1
13	Carboplatin plus pemetrexed for platinum-pretreated, advanced non-small cell lung cancer: a retro- spective study with pharmacogenctic cvaluatian 显示文摘	Metro G Chiari R Mare M	2011	Cancer Che- mother Pharmaco12011，68，6：	1
14	Epidermal growth factor receptor (EGFR) targeted therapies in non-small cell lung cancer (NSCLC) 显示文摘	Metro G Finocchiaro G Toschi L	2006	Rev Recent Clin Trials2006，1，1：	1
15	Anti-cancer therapy with EGFR inhibitors:factors of prognostic and predictive significance显示文摘	Metro G Finocchiaro G Cappuzzo F	2006	Ann Oncol2006，17，2：	1
16	Impact of celecoxib on eapeeitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase 11 study with biomarker evaluation 显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmacol2008，62，4：	1
17	Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase Ⅱ study with biomarker evaluation显示文摘	Fabi A Metro G Papaldo P	2008	Cancer Chemother Pharmaeol2008，62，4：	1
18	Emerging drugs for small cell lung cancer-an update 显示文摘	METRO G DURANTI S FISCHER M J	2012	Expert Opin Emerg Drugs2012，17，1：	1
19	Development of gemcitabine in non-small cell lung cancer:the Italian con-tribution显示文摘	Metro G Cappuzzo F Finocchiaro G		0，，5：	1
20	Development ofgemcitabine in non-small cell lung cancer: the Italian con- tribution 显示文摘	Metro G Cappuzzo F Finocchiaro G	2006	Ann Oncol2006，175，：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示